LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 28.21 | 84.90 | 1431 | 2091 | 0.6842 | 0.8424 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.92 | 84.90 | 2 | 2237 | 0.0009 | -0.5480 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.92 | 84.90 | 1422 | 2237 | 0.6355 | 0.8168 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.92 | 84.90 | 22 | 2237 | 0.0098 | -0.2488 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.92 | 84.90 | 1096 | 2237 | 0.4898 | 0.7193 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.92 | 84.90 | 1408 | 2237 | 0.6292 | 0.8130 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.92 | 84.90 | 1468 | 2237 | 0.6560 | 0.8291 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.62 | 84.90 | 6 | 2449 | 0.0024 | -0.4209 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.62 | 84.90 | 1468 | 2449 | 0.5993 | 0.7996 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.62 | 84.90 | 29 | 2449 | 0.0118 | -0.1986 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.62 | 84.90 | 1147 | 2449 | 0.4682 | 0.7104 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.62 | 84.90 | 1448 | 2449 | 0.5911 | 0.7946 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.62 | 84.90 | 1504 | 2449 | 0.6140 | 0.8086 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.32 | 84.90 | 3 | 2722 | 0.0011 | -0.4874 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.32 | 84.90 | 1566 | 2722 | 0.5752 | 0.7907 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.32 | 84.90 | 24 | 2722 | 0.0088 | -0.2232 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.32 | 84.90 | 1203 | 2722 | 0.4419 | 0.6988 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.32 | 84.90 | 1541 | 2722 | 0.5660 | 0.7850 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.32 | 84.90 | 1597 | 2722 | 0.5866 | 0.7978 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.03 | 84.90 | 5 | 2991 | 0.0017 | -0.4237 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.03 | 84.90 | 1619 | 2991 | 0.5412 | 0.7748 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.03 | 84.90 | 22 | 2991 | 0.0074 | -0.2311 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.03 | 84.90 | 1248 | 2991 | 0.4172 | 0.6872 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.03 | 84.90 | 1599 | 2991 | 0.5346 | 0.7705 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.03 | 84.90 | 1639 | 2991 | 0.5479 | 0.7790 | MN20160318_Q02 | K06 |